Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9615 posts found.

angiochip

Engineers create lab-grown heart and liver tissue for drug testing and discovery

March 10, 2016 Manufacturing and Production, Research and Development 3D, angiochip, artificial heart, drug delivery, innovation, liver, vessels

Researchers at University of Toronto have developed “person-on-a-chip” technology which sees the growing of realistic human tissues outside the body. …
News
genmab

Genmab Darzalex success triggers second milestone payment

March 10, 2016 Research and Development, Sales and Marketing Genmab, Janssen, daratumumab, darzalex, follicular lymphoma

Genmab says it has reached a $5 million milestone in its daratumumab collaboration with Janssen as a result of success …
News
wkd_logo

Tackling Chronic Kidney Disease – early action will aid prevention this World Kidney Day 2016

March 10, 2016 Medical Communications, Research and Development

Today (10th March) marks World Kidney Day 2016. Now in its 11th year, it is the largest such event focused …
Feature
pfizer_building

Pfizer enters $5 billion share buyback deal with Goldman Sachs

March 9, 2016 Business Services, Research and Development Pfizer, Share buyback, Stock, markets

US drug major Pfizer (NYSE: PFE) on Wednesday said it has entered into an accelerated share repurchase agreement with Goldman, …
News
abpi_reception_close_7

Pharma industry’s contribution to NHS medicines bill tops £1 billion

March 9, 2016 Manufacturing and Production, Medical Communications, Research and Development ABPI, PPRS, goodwill, pharma industry

The pharmaceutical industry has now contributed over £1 billion to the Department of Health towards the cost of new medicines …
News

Late-stage Pfizer drug study shows significant reduction in haemophilia B bleeding

March 9, 2016 Research and Development BeneFIX, Pfizer, haemophilia B

Pfizer on Wednesday said late-stage trials for its drug candidate to treat haemophilia B showed prophylactic use resulted in significant reduction …
News

TiGenix says additional data for stem cell product affirms safety profile

March 9, 2016 Research and Development Crohn’s disease, TiGenix, crohn's disease, drug trial

Belgian biotech firm TiGenix said the results of a 52-week follow-up study of its trial drug for a stem-cell condition …
News
karl_ludwig_kley

Merck chief executive Karl-Ludwig Kley to step down in April

March 9, 2016 Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley

 It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …
Appointment
biotrial_facility_rennes

French clinical trial tragedy “astonishing and unprecedented”, says report

March 9, 2016 Medical Communications, Research and Development Bial, Biotrial, France, clinical trial, death, rennes, tragedy

A report into the clinical trial tragedy in France in January has called the event “astonishing and unprecedented” but did …
News
peptimimesis

Ipsen and PeptiMimesis announce oncology research partnership

March 9, 2016 Research and Development INSERM, PeptiMimesis, ipsen, peptides

Specialist pharma company Ipsen is partnering with French start-up PeptiMimesis to develop and market of novel therapeutic peptides in oncology. …
News
clinical_trial

Crown Bioscience expands portfolio with PreClinOmics acquisition

March 9, 2016 Manufacturing and Production, Research and Development cardiovascular, collaboration, crown bioscience, metabolic, preclinomics

Crown Bioscience has announced the acquisition of PreClinOmics, which will see the US-based drug discovery solutions company expand its cardiovascular …
News
merckincweb2

MSD joins charity-industry partnership Dementia Consortium

March 9, 2016 Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium

The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …
News
medimmune_logo_on_building

AZ drug gets orphan status for rare inflammatory disease

March 9, 2016 Research and Development AstraZeneca, MEDI-551, MedImmune, orphan drug

AstraZeneca’s biologics R&D arm MedImmune has been granted Orphan Drug Designation by the FDA for its investigational anti-CD19 monoclonal antibody, …
News

Genmab ends ofatumumab trials for autoimmune conditions; to focus on multiple sclerosis

March 9, 2016 Research and Development Arzerra, GSK

Danish drug-company Genmab (Nasdaq Copenhagen: GEN) said it will discontinue the late-stage trials for Arzerra (ofatumumab) to develop a treatment for …
News

Medimmune gets US FDA fast track designation for flu drug

March 9, 2016 Research and Development

UK drug major AstraZeneca (LSE: ANZ) said its biologics R&D unit, MedImmune, has received Fast Track designation from the US …
News
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026